• Immunogenicity Assessment

    • Therapeutic In Silico Services
      • ISPRIâ„¢ Website
      • ISPRI Downselectâ„¢
      • ISPRI Quantifyâ„¢
      • ISPRI Analyzeâ„¢
      • ISPRI Evaluateâ„¢
      • ISPRI-HCPâ„¢
      • ISPRI Designâ„¢
      • PANDA® Screening
    • Vaccine In Silico Services
      • iVAXâ„¢
      • EpiCCâ„¢
      • Ancer®
      • PreVAXâ„¢
    • Lab Services
      • HLA Binding Assay
      • Naive CD4+ T Cell Assay
      • Innate Assay
    • Consulting Services
  • About Us
    • Leadership
    • Careers
  • Partner
  • Press
    • News
    • Events
    • Publications
  • Contact Us
Immune camouflage: Relevance to vaccines and human immunology

Immune camouflage: Relevance to vaccines and human immunology

by Annie De Groot | Jan 13, 2020

De Groot et al. – 2014 – Immune camouflage Relevance to vaccines and human immunology
Considerations for the rapid deployment of vaccines against H7N9 influenza

Considerations for the rapid deployment of vaccines against H7N9 influenza

by Adam | Oct 22, 2016

Considerations for the rapid deployment of vaccines against H7N9 influenza. University of Melborne. Expert Rev Vaccines. 2014 Jul 12
Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design

Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design

by Adam | Oct 22, 2016

Hum Vaccin Immunother. 2014 Feb Full Text
Integrated assessment of predicted MHC binding and cross-conservation with self reveals patterns of viral camouflage

Integrated assessment of predicted MHC binding and cross-conservation with self reveals patterns of viral camouflage

by Adam | Oct 22, 2016

BMC Bioinformatics 2014, 15 (Suppl 4): S1 doi:10.1186/1471-2105-15-S4-S1.
Peptide-pulsed dendritic cells induce the hepatitis C viral epitope-specific responses of naïve human T cells

Peptide-pulsed dendritic cells induce the hepatitis C viral epitope-specific responses of naïve human T cells

by Adam | Oct 22, 2016

Vaccine. 2014 May 30;32(26):3285-92. doi: 10.1016/j.vaccine.2014.03.083. Epub 2014 Apr 8.
« Older Entries

Recent Posts

  • The Amsterdam Immunogenicity & Tolerance Seminar: 2025
  • EpiVax Seminars in Tokyo
  • The Role of Treg Epitopes (Tregitopes) in Antibody Maturation Uncovered in New EpiVax Study: Implications for Therapeutic Antibodies
  • March of the Teenage B Cells
  • EpiVax Strengthens Technology Leadership Amid Immunoinformatics Advancements

Recent Comments

No comments to show.

Join our newsletter

 Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update written by EpiVax co-founder and CSO, Dr. Annie De Groot. 

Explore

Therapeutic In Silico Services

Vaccine In Silico Services

Lab Services

Consulting

LinkedIn

About Us

Careers

Partner

News

Events

Publications

Contact Us

We use cookies to ensure that we give you the best experience on our website. By clicking 'accept', you consent to our use of cookies.AcceptDecline